Stepwise approach to topical therapy for atopic dermatitis

Clinical Pediatrics

Volumn 47, Issue 5, 2008, Pages 423-434

  Palmer, Christine M ^a   Lyon, Valerie B ^a,b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b Department of Dermatology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACLOMETHASONE DIPROPIONATE; ALCLOMETASONE DIPROPIONATE; AMCINONIDE; BETAMETHASONE DIPROPIONATE; BETAMETHASONE VALERATE; CEFALEXIN; CEPHALOSPORIN; CLOBETASOL PROPIONATE; CORTICOSTEROID; DERMASMOOTHE; DESONIDE; DESOXIMETASONE; DEXAMETHASONE; DICLOXACILLIN; DIFLORASONE DIACETATE; EMOLLIENT AGENT; FLUDROXYCORTIDE; FLUOCINOLONE ACETONIDE; FLUOCINONIDE; FLUOCORTOLONE; FLUOCORTOLONE CAPROATE; FLUTICASONE PROPIONATE; HALCINONIDE; HYDROCORTISONE; HYDROCORTISONE BUTYRATE; HYDROCORTISONE VALERATE; LUXIQ; MOMETASONE FUROATE; PENICILLIN G; PIMECROLIMUS; PREDNICARBATE; TACROLIMUS; TOLNAFTATE; TRIAMCINOLONE; TRIAMCINOLONE ACETONIDE; ULOBETASOL PROPIONATE;

ACNE; ATOPIC DERMATITIS; ATROPHY; BIOPSY TECHNIQUE; CHEEK; CLINICAL TRIAL; DERMATOLOGY; DIFFERENTIAL DIAGNOSIS; FOLLOW UP; GENERAL PRACTITIONER; HUMAN; LEG; MONOTHERAPY; MORPHOLOGY; NOTE; OUTPATIENT DEPARTMENT; PRIMARY MEDICAL CARE; REMISSION; SKIN; STRIA; TELANGIECTASIA;

ADMINISTRATION, TOPICAL; DERMATITIS, ATOPIC; DRUG ADMINISTRATION SCHEDULE; HUMANS; INFANT; STEROIDS;

EID: 43049083347     PISSN: 00099228     EISSN: None     Source Type: Journal    
DOI: 10.1177/0009922807309422     Document Type: Note

References (21)

1. Paller AS, Mancini AJ Hurwitz Clinical Pediatric Dermatology. 3 rd ed. Philadelphia, PA: Elsevier Saunders ; 2006: 49-80.
2. Feldman S., Behnam SM, Behnam SE, Koo, JY Involving the patient: impact of inflammatory skin disease and patient-focused care. J AmAcad Dermatol. 2005 ; 53 (suppl): S78 - S85.
3. Eichenfield LF, Hanifin JM, Luger TA, Stevens SR, Pride HB Consensus conference on pediatric atopic dermatitis. J Am Acad Dermatol. 2003 ; 49: 1088-1095.
4. Hengge UR, Ruzicka T., Schwartz RA, Cork MJ Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol. 2006 ; 54: 1-15.
5. Schachner LA, Lamerson C., Sheehan MP, et al. Tacrolimus ointment 0.03% is safe and effective for the treatment of mild to moderate atopic dermatitis in pediatric patients: results from a randomized, double-blind, vehicle-controlled study. Pediatrics. 2005 ; 116: e334 - e342.
6. Eichenfield LF, Lucky AW, Boguniewicz M., et al. Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents. J Am Acad Dermatol. 2002 ; 46: 495-504.
7. Protopic prescribing information [package insert]. Astellas Pharma US, Inc. http://www.protopic.com. Accessed April 17, 2007.
8. Elidel prescribing information [package insert]. Novartis Pharmaceuticals Corp. http://www.elidel.com. Accessed April 17, 2007.
9. Hanifin JM, Hebert AA, Mays SR, et al. Effects of a low-potency corticosteroid lotion plus a moisturizing regimen in the treatment of atopic dermatitis. Curr Ther Res Clin Exp. 1998 ; 59: 227-233.
10. Lucky AW, Leach AD, Laskarzewski P., Wenck H. Use of an emollient as a steroid-sparing agent in the treatment of mild to moderate atopic dermatitis in children. Pediatr Dermatol. 1997 ; 14: 321-324.
11. Chamlin SL, Kao J., Frieden IF, et al. Ceramidedominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity. J Am Acad Dermatol. 2002 ; 47: 198-208.
12. Hanifin JM, Cooper KD, Ho VC, et al. Guidelines of care for atopic dermatitis. J Am Acad Dermatol. 2004 ; 50: 391-404.
13. Singh G., Singh PK Tachyphylaxis to topical steroid measured by histamine-induced wheal suppression. Int J Dermatol. 1986 ; 25: 324-326.
14. Singh S., Gupta A., Pandey SS, Singh G. Tachyphylaxis to histamine-induced wheal suppression by topical 0.05% clobetasol propionate in normal versus croton oil-induced dermatitic skin. Dermatology. 1996 ; 193: 121-123.
15. Feldman SR Tachyphylaxis to topical corticosteroids: the more you use them, the less they work? Clin Dermatol. 2006 ; 24: 229-230.
16. Nakahara T., Koga T., Fukagawa S., Uchi H., Furue M. Intermittent topical corticosteroid/tacrolimus sequential therapy improves lichenification and chronic papules more efficiently than intermittent topical corticosteroid/ emollient sequential therapy in patients with atopic dermatitis. J Am Acad Dermatol. 2004 ; 31: 524-528.
17. Paller AS, Lebwohl M., Fleischer AB Jr, et al. Tacrolimus ointment is more effective than pimecrolimus cream with a similar safety profile in the treatment of atopic dermatitis: results from 3 randomized, comparative studies. J Am Acad Dermatol. 2005 ; 52: 810-822.
18. Hanifin JM, Paller AS, Eichenfield L., et al. Efficacy and safety of tacrolimus ointment treatment for up to 4 years in patients with atopic dermatitis. J Am Acad Dermatol. 2005 ; 53: S186 - S194.
19. Papp KA, Werfel T., Fölster-Holst R., et al. Long-term control of atopic dermatitis with pimecrolimus cream 1% in infants and young children: a two-year study. J Am Acad Dermatol. 2005 ; 52: 240-246.
20. Ho VC, Gupta A., Kaufmann R., et al. Safety and efficacy of nonsteroid pimecrolimus cream 1% in the treatment of atopic dermatitis in infants. J Pediatr. 2003 ; 142: 155-162.
21. Patel RP, Vander Straten MR, Korman NJ The safety and efficacy of tacrolimus therapy in patients younger than 2 years with atopic dermatitis. Arch Dermatol. 2003 ; 139: 1184-1186.